Unexplained Recurrent Maternal Fever Leading To Fetal Demise: Role of Empirical Therapy For Successful Outcome

Background: Pyrexia of unknown origin (PUO) during pregnancy is uncommon and poses significant diagnostic and management challenges. It may reflect underlying immune dysregulation, contributing to adverse fetal outcomes. Case Presentation: We report a 26-year-old woman with recurrent mid-trimester high-grade fevers during two consecutive pregnancies, both ending in intrauterine fetal demise (IUFD). Extensive investigations failed to identify an infectious, malignant, or inflammatory cause. Placental histopathology revealed inflammatory changes. Lupus anticoagulant was later found to be positive. In her third pregnancy, early initiation of empirical immunosuppressive therapy—azathioprine, low-dose steroids, low-molecular-weight heparin, and aspirin—resulted in a successful outcome with delivery of a healthy infant. Conclusion: PUO in pregnancy may be a manifestation of immune dysregulation or fetal allograft rejection. In select cases, empirical immunomodulatory therapy instituted preconceptionally or early in pregnancy may improve outcomes. A high index of suspicion and multidisciplinary management are crucial in such scenarios.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-12-19
DOI
https://doi.org/10.5281/zenodo.17960660
Primary Topic
Hematological disorders and diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unexplained Recurrent Maternal Fever Leading To Fetal Demise: Role of Empirical Therapy For Successful Outcome

Zenodo (CERN European Organization for Nuclear Research)
Hematological disorders and diagnostics
article

Unexplained Recurrent Maternal Fever Leading To Fetal Demise: Role of Empirical Therapy For Successful Outcome

article en

Abstract

Background: Pyrexia of unknown origin (PUO) during pregnancy is uncommon and poses significant diagnostic and management challenges. It may reflect underlying immune dysregulation, contributing to adverse fetal outcomes. Case Presentation: We report a 26-year-old woman with recurrent mid-trimester high-grade fevers during two consecutive pregnancies, both ending in intrauterine fetal demise (IUFD). Extensive investigations failed to identify an infectious, malignant, or inflammatory cause. Placental histopathology revealed inflammatory changes. Lupus anticoagulant was later found to be positive. In her third pregnancy, early initiation of empirical immunosuppressive therapy—azathioprine, low-dose steroids, low-molecular-weight heparin, and aspirin—resulted in a successful outcome with delivery of a healthy infant. Conclusion: PUO in pregnancy may be a manifestation of immune dysregulation or fetal allograft rejection. In select cases, empirical immunomodulatory therapy instituted preconceptionally or early in pregnancy may improve outcomes. A high index of suspicion and multidisciplinary management are crucial in such scenarios.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 27%
Hematological disorders and diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.